March 28, 2018
A Massachusetts federal judge on Tuesday dropped a shareholder suit accusing the biopharmaceutical company Biogen Inc. of misrepresenting the effect that the death of a clinical study patient had on its sales, saying the allegations indicate Biogen was "unduly optimistic" rather than knowingly lying in their public disclosures.